Y 
38.09
-1.47%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$26.53trn
FY2016FY2025
Net income
−$1.20trn
FY2016FY2025
Free cash flow
−$171.22bn
FY2016FY2025
Shareholders' equity
$15.69trn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.53trn | $17.90trn | $5.48trn | $2.53trn | $1.32trn | $692.51bn | $678.60bn | $435.82bn | $252.81bn | $210.10bn |
| Gross profit | $7.16trn | $4.94trn | $969.46bn | $650.78bn | $294.87bn | $70.67bn | $108.13bn | $78.33bn | $42.29bn | $33.94bn |
| Research and development | — | $40.88bn | $18.40bn | $4.79bn | $1.94bn | $2.13bn | $1.26bn | $1.55bn | $449.0m | $400.0m |
| Operating income | $2.37trn | $1.16trn | −$878.52bn | $287.34bn | $126.79bn | −$58.40bn | $33.15bn | $60.24bn | $36.03bn | $10.42bn |
| Net income | −$1.20trn | $2.08trn | −$1.56trn | $289.06bn | $257.0m | −$69.65bn | −$34.07bn | $38.61bn | $12.34bn | −$28.24bn |
| Diluted earnings per share | -3,060.45 | 5,301.16 | -3,996.68 | 737.99 | 0.65 | -177.46 | -86.84 | 98.77 | 31.43 | -71.37 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $42.72trn | $30.27trn | $17.96trn | $4.59trn | $2.39trn | $1.92trn | $1.57trn | $994.02bn | $505.72bn | $421.14bn |
| Cash and short-term investments | $1.73trn | $1.55trn | $995.29bn | $193.36bn | $113.69bn | $83.55bn | $74.47bn | $56.97bn | $2.17bn | $1.14bn |
| Total liabilities | $26.69trn | $18.05trn | $11.47trn | $2.72trn | $1.54trn | $1.24trn | $1.03trn | $631.66bn | $353.19bn | $302.48bn |
| Debt | $16.18trn | $9.98trn | $6.98trn | $1.36trn | $812.84bn | $724.58bn | $588.54bn | $271.97bn | $153.77bn | $154.34bn |
| Shareholders' equity | $15.69trn | $12.00trn | $6.42trn | $1.85trn | $839.89bn | $677.23bn | $542.55bn | $359.20bn | $152.29bn | $118.75bn |
| Shares outstanding | 392m | 392m | 391m | 392m | 393m | 392m | 392m | 391m | 393m | 396m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $7.20trn | $5.87bn | $1.58trn | $736.66bn | $400.01bn | $209.22bn | $217.14bn | $125.06bn | $71.97bn | $49.18bn |
| Capital spending | −$7.37trn | −$5.39bn | −$1.59trn | −$532.13bn | −$234.80bn | −$114.62bn | −$161.46bn | −$88.29bn | −$59.62bn | −$64.16bn |
| Free cash flow | −$171.22bn | $477.0m | −$7.57bn | $204.53bn | $165.21bn | $94.60bn | $55.68bn | $36.77bn | $12.36bn | −$14.98bn |
| Dividends paid | — | — | — | — | — | — | −$2.30bn | −$1.20bn | −$716.0m | −$889.0m |
Financial ratios
Data as of 25 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 27.0% | 27.6% | 17.7% | 25.8% | 19.1% | 10.2% |
| Operating margin | 8.9% | 8.9% | -16.0% | 11.4% | 10.0% | -8.4% |
| Net margin | -4.5% | 11.6% | -28.5% | 11.4% | 0.0% | -10.1% |
| Return on equity | -7.6% | 17.3% | -24.3% | 15.6% | 3.2% | -10.3% |
| Return on assets | -2.8% | 6.9% | -8.7% | 6.3% | 1.1% | -3.6% |
| Free cash flow yield | 69361.9% | 53.6% | 55.3% | 46.2% | 31.6% | 17.6% |
| Revenue growth | 48.3% | 226.3% | 117.1% | 98.7% | 15926.4% | -50.3% |
| Earnings growth | -157.7% | -233.1% | -640.1% | 112373.5% | -132.2% | -0.4% |
| Current ratio | 0.87x | 0.78x | 0.90x | 1.08x | 1.19x | 0.88x |
| Debt to equity | 0.25x | 0.19x | 0.21x | 0.71x | 84.87x | 68.26x |
| Equity ratio | 36.7% | 39.6% | 35.7% | 40.3% | 35.1% | 35.2% |
| Interest coverage | 1.75x | 1.98x | -0.96x | 1.67x | 1.76x | -0.60x |
| R&D as a share of sales | 0.0% | 0.2% | 0.3% | 0.2% | 0.0% | 0.3% |
| Buybacks as a share of market value | 0.1% | -0.3% | 0.3% | 0.3% | -0.1% | -0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 119.0% | 107.3% | 67.1% |
| Operating income | 101.9% | — | 64.2% |
| Net income | — | 76.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 27.3% | 26.2% | 25.9% | 25.6% |
| Operating margin | 7.9% | 5.6% | 5.5% | 5.6% |
| Net margin | 2.0% | -0.7% | -0.8% | -0.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -0.0 | 0.0 | 0.0 | 5.8 | -0.0 | -0.1 | 0.1 | 0.7 | -0.2 | 1.4 |
| Price to sales | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Market value over time
31 Oct 2016 to 24 Sept 2026, in USD
$6.96bn$20.77bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -15% | 141% | 118% | 112% | -28% | -53% | -14% | -41% | 42% | -4% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.